Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Study sponsor: Polaris Group
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-08-15Actual
Enrollment · participants249Actual
Source updated2023-10-04Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.